Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Another Case of PML with Gilenya Reported by Novartis
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.
Dystonic pattern in a fibromyalgia patient: Relevance of a biopsychosocial rehabilitation approach.
Axon growth inhibition by RhoA/ROCK in the central nervous system.
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.
Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.
The effect of B-cell depletion in the Theiler's model of multiple sclerosis.
Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
Microglia-Mediated Inflammation and Neurodegenerative Disease.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.
Strength: A Relevant Link to Functional Performance in the Neurodegenerative Disease of Adrenomyeloneuropathy.
Vitamin d and multiple sclerosis: correlation, causality, and controversy.
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Improved Detection of Cortical Gray Matter Involvement in Multiple Sclerosis with Quantitative Susceptibility Mapping.
Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System.
Metabolomics in multiple sclerosis.
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial.
Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data.
Multiparity in women with multiple sclerosis causes less long-term disability: Commentary.
Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis.
Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population.
Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.
Pages
« first
‹ previous
…
669
670
671
672
673
674
675
676
677
…
next ›
last »